1,963 results on '"Potter V"'
Search Results
2. Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer: A Nested Case-control Matched Analysis of an International, Multi-centre, Randomised Controlled Trial (FOxTROT)
3. Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option
4. Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT
5. Correction to: ICU-outcomes in CAR-T patients—A single centre experience
6. EP08.02-108 Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
7. P1169: ELEVATED CRP AT INFUSION OF AXICABTAGENE CILOLEUCEL PREDICTS HIGH-GRADE CAR-T TOXICITY AND OUTPERFORMS MORE COMPLEX SCORES
8. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION
9. Haplotype motif-based models for KIR-genotype informed selection of hematopoietic cell donors fail to predict outcome of patients with Myelodysplastic Syndromes or secondary Acute Myeloid Leukemia (vol 11,& nbsp;584520, 2021)
10. Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis
11. Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics
12. An audit of stopping antifungal prophylaxis post allogeneic stem cell transplantation: 412
13. Anti-phospholipase A2 receptor (Anti-PLA2R) antibody positive-nephrotic syndrome as a manifestation of multi-system, immunemediated complications post allogeneic stem cell transplant: A case report: 410
14. FLAG-lite regimen is effective bridging salvage chemotherapy for relapsed/refractory acute myeloid Leukaemia - a single centre experience: 336
15. Brentuximab vedotin as a bridge to transplant in classical Hodgkin lymphoma: Single tertiary centre real-world experience: 262
16. Single UK centre outcomes of peripheral blood stem cell (PBSC) haploidentical transplantation: 20
17. Feasibility and optimal schedule of eculizumab in patients with haemolytic paroxysmal nocturnal hemoglobinuria (hPNH) with severe aplastic anaemia (SAA) prior to haemopoietic stem cell transplant (HSCT): 22
18. Holistic Assessment of Patientsʼ Concerns Prior to Autologous High Dose Melphalan (HDM) Haematopoietic Stem Cell Transplant (HSCT) for Plasma Cell Disorders (PCD).: NO005
19. PH-0329 Feasibility and outcome of bridging RT pre CAR-T in DLBCL in one centre with a wide referral network
20. PTU-079 Non-invasive testing is diagnostic and prognostic in intestinal graft versus host disease
21. OC-031 Rectogismoid biopsies are sufficient to confirm intestinal involvement in symptomatic patients with acute or chronic graft versus host disease: a retrospective observational study
22. Donor lymphocyte infusion - a retrospective single centre audit: 13
23. Immunological profile of patients after HSCT using the FCC conditioning regimen for treatment of severe aplastic anemia indicates potential basis for tolerance with mixed T-cell chimerism and extremely low incidence of GvHD: 12
24. Total body irradiation plus fludarabine compared to busulfan plus fludarabine as 'reduced-toxicity conditioning' for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
25. Purpose and Function of the University
26. EARLY PET RESPONSE PREDICTS OUTCOME IN LARGE B‐CELL LYMPHOMA PATIENTS TREATED WITH CD19 CAR‐T
27. RETROSPECTIVE COMPARISON OF HPC-A COLLECTION EFFICIENCY BETWEEN SPECTRA OPTIA® AND COBE SPECTRA® CELL SEPARATORS IN A LARGE TERTIARY COLLECTION FACILITY.: PH-AB200
28. EBV REACTIVATION AND PTLD IN PATIENTS RECEIVING HSCT FOR APLASTIC ANAEMIA: PH-AB075
29. PREDICTING FACTORS FOR INPATIENT MORTALITY AND LONG TERM SURVIVAL IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS ADMITTED TO INTENSIVE CARE UNIT: PH-P317
30. S103 Baseline CT thorax in patients undergoing allogeneic haematopoetic stem-cell transplantation and risk of invasive fungal disease- a prospective 5-year study
31. Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoeitic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
32. P-63 Real-world UK retrospective multi-centre review of the use of G-CSF in the prevention of chemotherapy-induced neutropenia in patients with CRC receiving trifluridine/tipiracil
33. Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients – the Diadem Study from the Chronic Malignancies Working Party of the EBMT
34. Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation (sUCBT): O388
35. Autoimmune haemolytic anaemia after allogeneic haematopoietic stem cell transplantation: analysis of 555 transplant patients at Kingʼs College Hospital: 37
36. Retrospective analysis of 5-azacitidine as induction therapy prior to haematopoietic stem cell transplantation: P1172
37. Biological Energy Transformations and the Cancer Problem
38. Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation
39. Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia
40. Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells
41. DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT-LWP STUDY
42. DNA encoding the scFv of the human anti-idiotypic antibody 105AD7 - studies comparing mono-, di- and trimeric constructs.
43. Cardiopoietic cell therapy for advanced ischemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
44. Purpose and Function of the University
45. CAR T treatment access and outcomes in patients with large B‐cell lymphoma according to ethnicity and socioeconomic deprivation.
46. Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer
47. Nivolumab (nivo) in combination with radiotherapy (RT) ± temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM)
48. Effects of a maternal high-fat diet on offspring behavioral and metabolic parameters in a rodent model
49. Beryllium Processing by Powder Metallurgy
50. M35 Adverse Effects Of Latent Tuberculosis Treatment In Migrants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.